BRCA1 and cancer: When BRCA1 is mutated or deleted, the levels of PERK and IRE1 proteins increase, leading to sustained activation of UPR, inhibition of protein folding, or UPR signaling significantly reduces the overall survival rate of BRCA1-deficient cancer cells [36].